Situation
A site adds a new product strength to an existing manufacturing execution system (MES) recipe. Equipment is unchanged, but material rules, set-point limits, and exception routing are configured locally.
Intended Use
Guide authorized operators through dispensing and processing, prevent use of incorrect material, enforce approved parameter ranges, and create the electronic batch record used for review.
Decision Summary
| Decision element | Case record |
|---|---|
| GxP assessment | Material identity, processing limits, exception routing, operator authorization, and the resulting batch record directly support controlled manufacturing and batch review. |
| Potential impact | Product can be manufactured with an incorrect material or parameter and the batch record can misrepresent the executed process. |
| Known issue | A fictional boundary execution accepts the upper limit after unit conversion because rounding occurs too early. |
| Validation conclusion | Release is withheld until conversion precision is corrected and the affected limits, exception route, and record output pass regression. |
GxP Assessment
Material identity, processing limits, exception routing, operator authorization, and the resulting batch record directly support controlled manufacturing and batch review.
Affected GxP Functions
- Recipe version and product selection
- Material and status verification
- Set-point and tolerance limits
- Exception routing and e-signature
- Electronic batch record generation
Failure Scenarios
- Wrong recipe version is selected
- An unapproved material is accepted
- A set point outside the approved range is permitted
- An exception bypasses required Quality review
- The record omits the executed recipe revision
Potential Impact
Product can be manufactured with an incorrect material or parameter and the batch record can misrepresent the executed process.
Existing Controls
- Approved master recipe
- Barcode material verification
- Role restrictions
- Independent batch-record review
- Equipment alarms
Existing Evidence
- Prior qualified MES platform
- Supplier standard-function regression
- Approved configuration specification
- Previous recipe tests
Evidence Gaps
- New strength and limits
- Legacy material-status combination
- Open exception during version activation
- Record display of recipe revision
Testing Approach
- Script exact material and parameter controls at boundaries
- Challenge unauthorized role and bypass paths
- Explore interruption and open-exception transition
- Verify audit history, signatures, and executed-record output
Deviations or Known Issues
A fictional boundary execution accepts the upper limit after unit conversion because rounding occurs too early.
Validation Conclusion
Release is withheld until conversion precision is corrected and the affected limits, exception route, and record output pass regression.
Reassessment Criteria
- Recipe or calculation change
- Material-master interface change
- MES platform release
- Exception or signature workflow change
- Related manufacturing deviation
Limitations and unresolved questions
Other strengths, units and recipes are not covered automatically. The upper-limit failure must be corrected and retested before the affected use is released.
Relevant regulations and guidance
These sources apply within their stated scope. The suggested worksheet fields, test designs and fictional decisions are practitioner recommendations, unless a source requirement is expressly identified. Completing a template does not establish compliance.
Computer Software Assurance for Production and Quality Management System Software ↗
Regulatory guidance / GMP guideline · United States · February 2026
Scope: Medical-device manufacturers assuring software used in production or their quality management system.
Relevance: For medical-device production or QMS software, supports selecting assurance activities from intended use, risk and available evidence. It is nonbinding guidance and does not determine other sectors’ obligations.
Status: Final / published · Checked 2026-09-21
Publication identity, scope and status checked against the linked official source. This is not an independent audit of every retained guide statement.
Read source details and applicability →EudraLex Volume 4, Annex 11 — Computerised Systems ↗
Regulatory guidance / GMP guideline · European Union · January 2011 revision
Scope: Computerised systems supporting activities in the applicable EU pharmaceutical GMP context.
Relevance: For computerised systems used in EU GMP activities, informs lifecycle, supplier and record controls. Confirm applicability to the actual activity; the example does not establish it.
Status: Final / published · Checked 2026-09-21
The Commission index confirms the January 2011 operative revision. The linked PDF could not be retrieved in this check; retained detailed section mappings need review against an authorized copy.
Read source details and applicability →Was this useful? Leave feedback
Was this resource useful?
Tell us what helped and what could be clearer. Usefulness feedback does not establish technical validity or regulatory compliance.
Loading contribution options…
Questions and moderated discussion
Questions and discussion
What additional information would you need before making this decision?
Loading contribution options…
Suggest a correction
Sent privately to the editorial moderation queue. Your account email and correction are not published as a comment. Do not include confidential or personal information.
Resource: MES Recipe Configuration Change
Loading sign-in status…